Plain-English translation of NCT07220824 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is watching how well guselkumab works for people with psoriatic arthritis — a condition where the immune system causes joint pain and swelling in people who also have psoriasis (red, scaly patches on the skin). Researchers will use ultrasound to see how much inflammation decreases in your joints over time. This is a real-world study, meaning you'll be receiving this medication as part of your normal medical care, not as an experimental treatment.
While this medication has been tested in clinical trials, researchers want to understand how well it works for everyday patients in regular medical practice. By using ultrasound imaging to track inflammation in detail, they hope to learn more about which patients benefit most from this treatment.
You likely qualify if…
You likely don't qualify if…
You would continue receiving your new medication through your regular doctor as part of normal care — the study does not provide the medication. Researchers will collect information from your routine doctor visits and ultrasound scans already being done for your care, and they will ask you questions about how you're feeling and your overall health. There is no additional drug being tested, just careful observation and data collection from your existing medical visits.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Italy